PERICOLINI, Eva
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.030
AS - Asia 6.863
EU - Europa 6.331
SA - Sud America 1.016
AF - Africa 194
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.746
SG - Singapore 2.182
GB - Regno Unito 1.820
CN - Cina 1.640
IT - Italia 1.522
HK - Hong Kong 817
BR - Brasile 738
VN - Vietnam 706
DE - Germania 552
SE - Svezia 500
RU - Federazione Russa 282
FR - Francia 277
UA - Ucraina 259
FI - Finlandia 251
IN - India 234
TR - Turchia 230
KR - Corea 225
ID - Indonesia 201
PL - Polonia 159
CA - Canada 121
BG - Bulgaria 120
MX - Messico 107
AR - Argentina 92
BD - Bangladesh 91
IQ - Iraq 81
RO - Romania 78
NL - Olanda 74
JP - Giappone 71
ZA - Sudafrica 63
BE - Belgio 62
ES - Italia 48
EC - Ecuador 45
IE - Irlanda 45
MY - Malesia 45
AU - Australia 43
CL - Cile 43
PK - Pakistan 43
AT - Austria 41
LT - Lituania 41
AE - Emirati Arabi Uniti 40
HU - Ungheria 39
IR - Iran 39
CO - Colombia 34
PT - Portogallo 31
EG - Egitto 29
CH - Svizzera 26
MA - Marocco 25
PE - Perù 25
TH - Thailandia 25
UZ - Uzbekistan 25
NO - Norvegia 22
PH - Filippine 21
IL - Israele 20
DZ - Algeria 17
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
TW - Taiwan 16
PY - Paraguay 15
VE - Venezuela 15
AZ - Azerbaigian 12
NP - Nepal 12
DO - Repubblica Dominicana 11
GR - Grecia 11
JO - Giordania 11
KE - Kenya 11
TN - Tunisia 11
JM - Giamaica 10
NZ - Nuova Zelanda 10
BB - Barbados 9
DK - Danimarca 9
KW - Kuwait 8
OM - Oman 8
SK - Slovacchia (Repubblica Slovacca) 8
BO - Bolivia 6
ET - Etiopia 6
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
UG - Uganda 6
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
AL - Albania 4
CG - Congo 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
GT - Guatemala 4
HN - Honduras 4
LK - Sri Lanka 4
MT - Malta 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
GH - Ghana 3
Totale 27.448
Salva come PNG Salva come JPEG
Città #
Singapore 1.567
Santa Clara 1.514
Fairfield 1.343
Ashburn 1.186
Southend 1.065
Woodbridge 787
Hong Kong 776
Chandler 631
Houston 566
San Jose 499
Seattle 490
Wilmington 422
Jacksonville 387
Hefei 383
Cambridge 382
Dearborn 380
Beijing 371
Council Bluffs 358
London 317
Ann Arbor 311
Nyköping 262
Modena 255
Ho Chi Minh City 215
Seoul 201
Los Angeles 179
Hanoi 156
The Dalles 154
New York 152
Helsinki 146
Jakarta 138
San Diego 121
Sofia 113
Princeton 103
Milan 102
Kraków 101
Bremen 99
Lauterbourg 99
Buffalo 93
Eugene 91
Dallas 89
Bologna 85
Moscow 83
Chicago 77
Redwood City 75
São Paulo 74
Orem 68
Izmir 64
Tokyo 61
Timisoara 57
Carpi 54
Chennai 54
Exeter 54
Shanghai 54
Rome 52
Nuremberg 50
Reggio Emilia 48
Haiphong 42
Munich 42
Guangzhou 41
Frankfurt am Main 39
Warsaw 39
Columbus 38
Johannesburg 38
Nanjing 38
Phoenix 38
Da Nang 37
Dublin 37
Parma 37
Mexico City 36
Boardman 35
Dong Ket 32
Atlanta 31
Brussels 31
Montreal 29
Porto Alegre 29
Verona 29
Baghdad 28
Brooklyn 27
Denver 27
Mumbai 27
Perugia 27
Salt Lake City 27
Stockholm 25
Trieste 25
Amsterdam 24
Poplar 24
Toronto 24
Boston 23
Dongguan 23
Falls Church 23
Norwalk 23
Rio de Janeiro 23
Kent 22
Lappeenranta 21
Basingstoke 20
Istanbul 20
Tashkent 20
Wuhan 20
Kuala Lumpur 19
Florence 18
Totale 18.892
Salva come PNG Salva come JPEG
Nome #
Zinc treatment prevents neutrophil recruitment and inflammation by blocking Candida albicans Pra1 during vulvovaginal candidiasis. 768
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 470
Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response 440
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 387
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 352
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 352
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 346
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 341
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 338
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 328
Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway 326
Effects of different mouthwashes on biofilm formation by oral streptococci 307
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 305
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 302
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 299
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 294
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 293
Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study 293
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 292
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 290
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 289
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 287
A Purified Capsular Polysaccharide Markedly Inhibits Inflammatory Response during Endotoxic Shock 285
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 280
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration 279
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity 275
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 269
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 260
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice 257
Hyphal morphology, molecular genetics and phylogenetic relationships among commensal and pathogenic vulvovaginal isolates of Candida albicans 255
A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production 250
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis 250
A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice 246
The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection 245
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 243
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 241
Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. 239
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence 239
Peptides of the constant region of antibodies display fungicidal activity 238
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 237
Mouse Strain-Dependent Differences in Estrogen Sensitivity During Vaginal Candidiasis 237
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 234
Inflammatory response during human vaginal infection with Candida albicans 230
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients 230
Role of CD45 signaling pathway in Galactoxylomannan-induced T cell damage 229
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy 226
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration. 225
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 225
Experimental models of vaginal candidiasis and inflammation 219
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans 218
A role for secretory aspartyl proteinase of Candida albicans in mouse vaginal inflammation and vaginal candidiasis 216
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 215
Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression 215
The Candida albicans Pra1 zincophore promotes neutrophils recruitment and inflammation during vulvovaginal candidiasis 214
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis 212
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 212
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 211
Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis 207
GILZ restrains neutrophil activation by inhibiting the MAPK pathway 207
Chronic vaginal candidiasis is achievable in outbred CD-1 mice 205
Gray phenotype: enhanced fitness strategy for Candida dubliniensis 204
Comparative analysis of commensal and pathogenic vulvovaginal clinical isolates of Candida albicans: hyphal morphology, molecular genetics and phylogenetic relationships 204
Saccharomyces cerevisiae as a new therapeutic agent against oropharyngeal candidiasis 203
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges 202
Involvement of glycoreceptors in galactoxylomannan-induced T cell death 202
Elucidating the immunological function of the Cryptococcus neoformans capsule 201
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 200
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 200
A role for Cryptococcus neoformans galactoxylomannan in T cell apoptosis and function. 198
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response. 197
It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset 197
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 196
Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor 194
Indinavir influences biological function of dendritic cells and stimulates antifungal immunity 194
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response 192
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 188
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts 188
Cryptococcus neoformans capsular polysaccharide component Galactoxylomannan induces apoptosis of human T cells through activation of Caspase-8 188
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 188
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection 186
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 185
A microbial polysaccharide reduces the severity of rheumatoid arthtritis via inhibition of Th17 differentiation 184
Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars 184
Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome 183
Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages 182
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 181
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 181
Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages 180
The Propionibacterium spp. extract reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 178
Therapeutic activity of Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 177
A new strategy to prevent biofilm and clot formation in medical devices: the use of atmospheric non-thermal plasma assisted deposition of silver-based nanostructured coatings 175
In vivo colonization and pathogenic potential of C. africana 173
In vivo induction of neutrophils chemotaxis by secretory aspartyl proteinases of Candida albicans 173
Comparison between bioluminescence imaging technique and CFU count for the study of oropharyngeal candidiasis in mice 172
The pathogenic and colonization potential of Candida africana 171
Any antibody fragment might exert antifungal activity 169
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 167
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 162
The Propionibacterium spp. extract P40 reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 161
A role for secretory aspartyl proteinases of Candida albicans in mouse vaginal inflammation and vaginal candidiasis 156
Totale 24.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 0 0 0 0 0 248 154
2021/20221.936 134 206 273 91 46 98 103 92 197 166 330 200
2022/20232.193 181 161 202 203 293 272 67 212 298 62 122 120
2023/20241.961 80 124 147 123 244 251 142 252 73 163 149 213
2024/20255.335 200 120 127 394 1.165 850 266 365 519 383 430 516
2025/20268.390 542 380 572 1.171 1.275 706 1.168 559 935 1.071 11 0
Totale 27.762